In the published article, there was an error. In Table 1, the percentage of HLA DQA1*05 carriage for “all cohort” was incorrect and was corrected to 40% (168/415).
In the Abstract, and Results, section 3.2. Impact of PPF of PK origin on Immune response during treatment, there was an error in the p value reported: “Overall, each incremental PPF of PK origin resulted in a 2-fold (OR=2.16, 95%CI: 1.7-2.7; p<0.11) higher likelihood of antidrug antibody formation”.
The corrected sentence appears below:
“Overall, each incremental PPF of PK origin resulted in a 2-fold (OR=2.16, 95%CI: 1.7-2.7; p<0.01) higher likelihood of antidrug antibody formation”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.